Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PARAVAC

Financiado

Cerrado

Vaccines against helminth infections

Livestock production efficiency is impaired by helminth infection which is ubiquitous in cattle, sheep and goats world-wide. It causes severely debilitating gastro-intestinal, respiratory and hepatic disorders, dependent on the in... ver más

31/03/2015

MRI

12M€

Presupuesto del proyecto: 12M€

Líder del proyecto

MOREDUN RESEARCH INSTITUTE No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 27 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-03-31 No tenemos la información de la convocatoria

0% 72% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

27 Participantes

MRI

0.00€ | Lider

UNIVERSITY OF GLASGOW

N.D. | Participante

ROYAL INSTITUTION FOR THE AD...

NOVAVAX AB

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AGL2014-54049-R INMUNIZACION FRENTE A LA HEMONCOSIS OVINA CON EL ANTIGENO RE... 121K€ Cerrado

NEMATODESYSTEMHEALTH A Systems Biology Approach to controlling Nematode Infection... 3M€ Cerrado

DESARROLLO DE AUTOVACUNAS FRENTE A ACTINOBACI... DESARROLLO DE AUTOVACUNAS FRENTE A ACTINOBACILLUS PLEUROPNEU... 265K€ Cerrado

AGL2009-09985 REDUCCION IN VIVO DE LINFOCITOS GAMMA DELTA Y EOSINOFILOS Y... 76K€ Cerrado

Paragone PARAGONE vaccines for animal parasites 9M€ Cerrado

AGL2016-79813-C2-2-R CONTROL DE LAS TRICOSTRONGILIDOSIS OVINAS: DISEÑO, SINTESIS... 79K€ Cerrado

Líder del proyecto

MOREDUN RESEARCH INSTITUTE No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 12M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Livestock production efficiency is impaired by helminth infection which is ubiquitous in cattle, sheep and goats world-wide. It causes severely debilitating gastro-intestinal, respiratory and hepatic disorders, dependent on the infecting species. The treatment and prevention of helminth parasitism in livestock continues to rely almost exclusively on the use of anthelmintic drugs, an approach threatened by the global emergence of anthelmintic resistance. An alternative approach is vaccination. Members of the present consortium (from the EU and Switzerland, North and South America, North and South Africa, Australia, 2 SMEs and 1 major animal health company) have developed prototype vaccines with the predicted required efficacy to control major gastro-intestinal nematode infections of livestock, notably Ostertagia ostertagi in cattle and Haemonchus contortus in sheep, the liver fluke Fasciola hepatica in sheep and cattle with leading positions in subunit vaccine development against Cooperia onchophora, Dictyocaulus viviparus in cattle and the tapeworm Echinococcus granulosus in dogs. This proposal aims to deliver at least one prototype vaccine to the point of uptake by the commercial sector or through government/philanthropic agencies and this will be addressed by 1) Developing effective native or synthetic vaccines, the latter using novel, molecular expression systems. 2) Defining the protective immune responses induced by these vaccines to order to optimise the structure of the antigens and the method of their delivery. 3) Defining vaccine efficacy with trials in both housed and grazing livestock 4) Providing a platform for training and knowledge exchange which includes participation in training programmes, short exchanges of staff, workshops,and web site provision. 5) Interacting closely with computer modellers, the animal health industry, farmer organisations and other stakeholders to define required vaccine characteristics. 6) Knowledge exchange/dissemination to policy makers, scientists, government departments and the general public.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores